Tenax Therapeutics (NASDAQ: TENX) revenue
Tenax Therapeutics reported revenue of $0.0m for fiscal 2025; in fiscal 2024 it was $0.0m.
Fiscal 2025 is the highest of the 3 fiscal years on record for Tenax Therapeutics.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $0.0m | — | −$56.4m | — |
| 2024 | $0.0m | — | −$19.5m | — |
| 2016 | $0.0m | — | −$52.7m | — |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Tenax Therapeutics revenue compared with its sector
By revenue for its latest fiscal year, Tenax Therapeutics ranks 421st of the 422 US health care companies with a page on Celsmar.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 418th | Spruce Biosciences | $0.0m | −100.0% |
| 419th | Scholar Rock | $0.0m | — |
| 420th | Spyre Therapeutics | $0.0m | — |
| 421st | Tenax Therapeutics | $0.0m | — |
| 422nd | Zentalis Pharmaceuticals | $0.0m | −100.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Tenax Therapeutics
- How much revenue did Tenax Therapeutics make in fiscal 2025?
- Tenax Therapeutics reported revenue of $0.0m for fiscal 2025, compared with $0.0m in fiscal 2024.
- What was the best year for revenue at Tenax Therapeutics?
- Of its last 3 fiscal years, fiscal 2025, with $0.0m.
- Where does Tenax Therapeutics rank in its sector by revenue?
- It ranks 421st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Tenax Therapeutics come from?
- From the annual report (Form 10-K) that Tenax Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Tenax Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2016. More on Tenax Therapeutics: the Tenax Therapeutics page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.